(13-170) Evaluation of Outcomes with Long-Acting Cabotegravir/Rilpivirine at a County Clinic

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: Harris Health System
Residency Program Type: PGY2 (Ambulatory Care Pharmacy)
Residency Program Location: Texas

Co-Author(s): Dominique Brewster, Cesar Munoz, Juliet Chijioke

Primary Author(s)